Collecting patient outcomes for chronic pain treatments
A DirEct to PatieNt Study in Chronic Pain
This study is collecting feedback from adults with chronic pain to see how well different approved treatments are working for them in real life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50000 (estimated) |
| Ages | 22 Years and up |
| Sex | All |
| Sponsor | Boston Scientific Corporation Industry-sponsored |
| Locations | 1 site (Valencia, California) |
| Trial ID | NCT05515341 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather real-world clinical outcomes and objective metrics from patients who are receiving or planning to receive commercially approved interventional medical devices or therapies for chronic pain. The study focuses on understanding the effectiveness of these treatments in routine clinical practice by collecting data directly from patients. Participants will self-report their experiences and outcomes related to their chronic pain management. The study will include patients aged 22 and older who are proficient in English.
Who should consider this trial
Good fit: Ideal candidates are adults aged 22 and older who are planning to receive or have already received a commercially approved interventional medical device for chronic pain.
Not a fit: Patients who require a legal representative to sign the informed consent form will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the effectiveness of chronic pain treatments, potentially improving patient care and treatment options.
How similar studies have performed: Other studies have shown success in collecting real-world data on chronic pain treatments, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Key Inclusion Criteria: * Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting * Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening * Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English Key Exclusion Criteria: * Requires a legal representative to sign the ICF ascertained from self-reporting
Where this trial is running
Valencia, California
- Boston Scientific Neuromodulation — Valencia, California, United States (Recruiting)
Study contacts
- Study coordinator: Alison Lewis
- Email: BSNClinicalTrials@bsci.com
- Phone: 855-213-9890
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.